HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

6th Edition of Cardiology World Conference

September 15-17, 2025 | London, UK

September 15 -17, 2025 | London, UK
Cardio 2025

The role of normal-range troponin trends in predicting cardiac function decline: Reducing echo dependency in the ED

Omar Sami Abdelhai, Speaker at Cardiology Conferences
Henry Ford Health, United States
Title : The role of normal-range troponin trends in predicting cardiac function decline: Reducing echo dependency in the ED

Abstract:

Background: Left ventricular systolic function is not well-characterized in patients with low high-sensitivity cardiac troponin I (hs-cTnI) evaluated in the Emergency Department (ED).

Methods: A stepped-wedge randomized trial conducted from July 2020 to March 2021, involved patients being evaluated for myocardial infarction (MI) using a 0/1-hour protocol in 9 EDs within Henry Ford Health in Detroit, Michigan. Our analysis focused on 737 patients with ejection fraction (EF) data. All patients had hs-cTnI ≤ 18 ng/L (MI threshold, Beckman Coulter) in the ED.??Patients were grouped by hs-cTnI terciles (<4, 4–6, and 7–18 ng/L), and EF was categorized as normal (≥50%), mildly reduced (41-49%), and reduced (≤40%).

Results: As seen in the Figure below, as hs-cTnI levels increase there is a noticeable decline in the proportion of patients with a normal EF. In patients with the lowest hs-cTnI levels, nearly all maintain a normal EF>50%. As the hs-cTnI levels increase, the proportion of patients with an EF <40% continues to increase.

Conclusion: These findings suggest a trend of decreasing ejection fraction as hs-cTnI levels increase, with a notable rise in the proportion of patients having an EF ≤40% in the highest hs-cTnI group.?Patients with hs-cTnI<4 ng/L in the ED are very unlikely to have left ventricular systolic dysfunction.

Biography:

Dr. Abdelhai completed medical school at the University of Jordan and currently in Internal Medicine residency at Henry Ford Hospital, Detroit, MI. Currently a second-year resident, Dr. Abdelhai has a strong interest in cardiology, with a focus on hemodynamics, structural interventions, and advanced heart failure. He has contributed to multiple research projects on ECMO outcomes, transcatheter valve therapies, and cardiac biomarkers, with presentations at national and international conferences. Passionate about bridging clinical practice and research, he aims to advance patient care through innovative studies and evidence-based medicine.

Watsapp